See more : NDT Pharmaceuticals Inc. (NDTP) Income Statement Analysis – Financial Results
Complete financial analysis of Ventas, Inc. (VTR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ventas, Inc., a leading company in the REIT – Healthcare Facilities industry within the Real Estate sector.
You may be interested
- IGB Real Estate Investment Trust (5227.KL) Income Statement Analysis – Financial Results
- Central Security Patrols Co., Ltd. (9740.T) Income Statement Analysis – Financial Results
- Bilcare Limited (BI.BO) Income Statement Analysis – Financial Results
- Liminal BioSciences Inc. (LMNL) Income Statement Analysis – Financial Results
- C-Tech United Corp. (3625.TWO) Income Statement Analysis – Financial Results
Ventas, Inc. (VTR)
About Ventas, Inc.
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries: healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.50B | 4.13B | 3.83B | 3.80B | 3.87B | 3.75B | 3.57B | 3.44B | 3.29B | 3.08B | 2.81B | 2.49B | 1.76B | 1.02B | 931.58M | 929.77M | 771.79M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Cost of Revenue | 3.73B | 2.28B | 2.09B | 1.94B | 1.81B | 1.69B | 1.49B | 1.44B | 1.41B | 1.21B | 1.12B | 979.23M | 678.64M | 325.47M | 302.81M | 306.94M | 198.13M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 770.72M | 1.85B | 1.74B | 1.86B | 2.06B | 2.05B | 2.09B | 2.00B | 1.88B | 1.86B | 1.69B | 1.51B | 1.09B | 691.40M | 628.76M | 622.82M | 573.67M | 418.45M | 324.72M | 232.91M | 205.00M | 196.70M | 204.58M | 242.32M | 233.25M | 149.93M | 3.12B | 2.58B | 2.32B |
| Gross Profit Ratio | 17.14% | 44.71% | 45.44% | 48.89% | 53.25% | 54.85% | 58.41% | 58.12% | 57.09% | 60.59% | 60.22% | 60.60% | 61.55% | 67.99% | 67.49% | 66.99% | 74.33% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | -0.01 | 0.02 | 0.09 | 0.10 | 0.10 | 0.36 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 0.00 | 0.00 | 38.83M | 36.43M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 148.88M | 144.87M | 129.76M | 130.16M | 166.00M | 151.98M | 135.49M | 126.88M | 128.04M | 121.75M | 115.11M | 98.80M | 74.54M | 49.83M | 38.83M | 40.65M | 36.43M | 26.14M | 23.10M | 16.92M | 12.72M | 9.76M | 10.24M | 9.69M | 7.77M | 5.70M | 0.00 | 1.49B | 0.00 |
| Other Expenses | 0.00 | 1.22B | 1.19B | 1.13B | 1.05B | -66.77M | -20.05M | -9.99M | -17.96M | -38.93M | -18.73M | -6.96M | 0.00 | 0.00 | 263.98M | 161.70M | 161.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.94B | 1.36B | 1.32B | 1.26B | 1.21B | 1.07B | 1.02B | 1.03B | 1.02B | 948.66M | 837.07M | 824.78M | 365.13M | 265.22M | 244.49M | 274.35M | 246.12M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Cost & Expenses | 3.83B | 3.65B | 3.41B | 3.20B | 3.02B | 2.76B | 2.51B | 2.47B | 2.43B | 2.16B | 1.96B | 1.80B | 1.04B | 590.69M | 547.30M | 581.30M | 444.24M | 154.55M | 100.61M | 68.50M | 66.64M | 69.49M | 63.27M | 64.03M | 100.66M | 37.97M | 2.79B | 2.53B | 2.32B |
| Interest Income | 0.00 | 463.92M | 425.28M | 7.61M | 10.98M | 24.89M | 6.03M | 876.00K | 1.05M | 4.27M | 2.05M | 1.11M | 0.00 | 0.00 | 842.00K | 2.96M | 2.99M | 2.89M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 574.11M | 467.56M | 440.09M | 469.54M | 451.66M | 442.50M | 448.20M | 419.74M | 367.11M | 376.84M | 334.48M | 293.40M | 236.81M | 178.86M | 176.99M | 203.18M | 204.22M | 136.54M | 0.00 | 0.00 | 80.20M | 86.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 1.17B | 3.60B | 3.22B | 3.05B | 2.87B | 2.80B | 2.50B | 2.44B | 979.11M | 828.16M | 753.14M | 724.83M | 459.70M | 214.71M | 207.61M | 235.72M | 237.50M | 119.65M | 88.00M | 54.34M | 39.51M | 41.25M | 40.37M | 43.60M | 42.80M | 29.05M | 123.87M | 99.53M | 89.48M |
| EBITDA | 1.83B | 1.65B | 1.60B | 1.72B | 1.93B | 1.80B | 1.95B | 1.95B | 1.81B | 1.70B | 1.59B | 1.42B | 1.00B | 609.50M | 578.87M | 584.19M | 549.60M | 399.04M | 312.11M | 212.99M | 159.19M | 171.07M | 185.09M | 191.26M | 177.93M | 141.01M | 451.07M | 147.54M | 97.84M |
| EBITDA Ratio | 40.71% | 40.00% | 41.91% | 45.40% | 49.95% | 48.04% | 54.49% | 54.57% | 55.19% | 55.40% | 56.54% | 57.07% | 66.91% | 62.96% | 63.54% | 62.83% | 73.21% | 91.96% | 96.60% | 66.25% | 77.65% | 86.97% | 90.47% | 151.09% | 76.29% | 94.05% | 14.48% | 5.72% | 4.21% |
| Operating Income | 665.12M | 454.08M | 389.30M | 592.58M | 865.76M | 861.09M | 622.09M | 556.79M | 834.72M | 875.84M | 835.80M | 693.64M | 51.17M | 52.22M | 208.12M | 145.29M | 126.32M | 125.42M | 100.22M | 87.10M | 119.68M | 129.82M | 144.72M | 322.51M | 135.13M | 111.96M | 327.20M | 48.01M | 8.36M |
| Operating Income Ratio | 14.79% | 11.00% | 10.17% | 15.61% | 22.36% | 22.99% | 17.41% | 16.17% | 25.40% | 28.48% | 29.74% | 27.91% | 2.90% | 5.13% | 22.34% | 15.63% | 16.37% | 29.97% | 30.86% | 37.39% | 58.38% | 66.00% | 70.74% | 133.09% | 57.94% | 74.68% | 10.50% | 1.86% | 0.36% |
| Total Other Income/Expenses | -704.95M | -511.94M | -1.55B | -1.35B | -618.83M | -569.59M | -644.18M | -354.58M | -118.78M | -8.73M | -11.83M | -79.43M | -210.39M | -202.44M | -190.06M | -185.42M | -174.43M | -136.54M | -103.21M | -42.85M | -47.89M | -79.14M | -163.98M | -252.50M | -247.28M | -124.73M | -102.74M | 35.18M | 24.00M |
| Income Before Tax | -39.84M | -57.86M | 61.39M | 344.65M | 382.99M | 376.04M | 584.15M | 522.87M | 350.26M | 448.38M | 478.48M | 298.27M | 330.44M | 227.13M | 194.27M | 145.29M | 120.35M | 130.58M | 120.90M | 100.17M | 96.73M | 50.69M | 54.28M | -61.25M | 42.54M | 55.96M | 224.47M | 83.18M | 32.36M |
| Income Before Tax Ratio | -0.89% | -1.40% | 1.60% | 9.08% | 9.89% | 10.04% | 16.34% | 15.18% | 10.66% | 14.58% | 17.03% | 12.00% | 18.72% | 22.34% | 20.85% | 15.63% | 15.59% | 31.21% | 37.23% | 43.01% | 47.19% | 25.77% | 26.53% | -25.27% | 18.24% | 37.32% | 7.20% | 3.23% | 1.39% |
| Income Tax Expense | -9.54M | -16.93M | 4.83M | -96.53M | -56.31M | -39.95M | -59.80M | -31.34M | -39.28M | -8.73M | -11.83M | -6.28M | -31.14M | 5.20M | -1.72M | -15.89M | -28.04M | 132.47M | 93.53M | 43.52M | -22.91M | -2.20M | 2.69M | 243.75M | 91.30M | 21.15M | 89.34M | 35.18M | 24.00M |
| Net Income | -40.97M | -40.93M | 49.01M | 439.15M | 433.02M | 409.47M | 1.36B | 649.23M | 417.84M | 475.77M | 453.51M | 362.80M | 364.49M | 246.17M | 266.50M | 226.29M | 282.32M | 131.43M | 130.58M | 120.90M | 162.75M | 65.71M | 50.57M | -65.45M | 42.54M | 26.76M | 130.93M | 48.01M | -14.89M |
| Net Income Ratio | -0.91% | -0.99% | 1.28% | 11.57% | 11.18% | 10.93% | 37.95% | 18.85% | 12.71% | 15.47% | 16.14% | 14.60% | 20.65% | 24.21% | 28.61% | 24.34% | 36.58% | 31.41% | 40.21% | 51.91% | 79.39% | 33.40% | 24.72% | -27.01% | 18.24% | 17.85% | 4.20% | 1.86% | -0.64% |
| EPS | -0.10 | -0.11 | 0.13 | 1.18 | 1.18 | 1.15 | 3.82 | 1.88 | 1.26 | 1.62 | 1.55 | 1.24 | 1.60 | 1.57 | 1.75 | 1.62 | 2.26 | 1.26 | 1.37 | 1.45 | 2.05 | 0.95 | 0.74 | -0.96 | 0.63 | 0.39 | 1.90 | 0.68 | -0.24 |
| EPS Diluted | -0.10 | -0.11 | 0.13 | 1.17 | 1.17 | 1.14 | 3.78 | 1.86 | 1.25 | 1.60 | 1.54 | 1.23 | 1.58 | 1.56 | 1.74 | 1.62 | 2.25 | 1.25 | 1.36 | 1.43 | 2.03 | 0.93 | 0.73 | -0.96 | 0.63 | 0.39 | 1.86 | 0.68 | -0.21 |
| Weighted Avg Shares Out | 401.81M | 373.37M | 382.79M | 373.37M | 365.98M | 356.27M | 355.33M | 344.70M | 330.31M | 294.18M | 292.65M | 292.06M | 228.45M | 156.61M | 152.57M | 139.57M | 122.60M | 104.21M | 95.04M | 83.49M | 79.34M | 69.34M | 68.41M | 68.01M | 67.75M | 67.68M | 68.94M | 69.70M | 62.32M |
| Weighted Avg Shares Out (Dil) | 401.81M | 373.37M | 386.30M | 376.50M | 369.89M | 359.30M | 358.57M | 348.39M | 334.01M | 296.68M | 295.11M | 294.49M | 230.79M | 157.66M | 152.76M | 139.91M | 123.01M | 104.73M | 95.78M | 84.35M | 80.09M | 70.29M | 69.36M | 68.13M | 67.99M | 68.61M | 70.36M | 70.70M | 71.97M |
Ventas Declares Second Quarter 2024 Dividend of $0.45 Per Common Share
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today announced that its Board of Directors has declared a quarterly dividend of $0.45 per common share. The dividend will be payable in cash on July 18, 2024 to stockholders of...
3 Cheap REITs to Buy Now: May 2024
Real estate is the worst-performing sector, down over 5% year-to-date (YTD). Due to higher for longer rates, there has been a broad-based selloff.
Ventas to Participate in Investor Meetings at BMO 2024 Real Estate Conference
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) announced today that management will participate in investor meetings at the BMO 2024 Real Estate Conference on May 8, 2024. About Ventas Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) is a leading S&P 500...
Ventas (VTR) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Ventas (VTR) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ventas (VTR) Q1 FFO Beats Estimates on Higher Same-Store NOI
Ventas' (VTR) Q1 results outshine estimates on better-than-anticipated revenues. The same-store NOI improves year over year on strong performance.
Ventas, Inc. (VTR) Q1 2024 Earnings Call Transcript
Ventas, Inc. (NYSE:VTR ) Q1 2024 Earnings Conference Call May 2, 2024 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP...
Ventas Reports 2024 First Quarter Results
CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) today reported results for the first quarter ended March 31, 2024. CEO Remarks “2024 is off to a strong start, led by continued organic growth in our advantaged senior housing operating...
Exploring Analyst Estimates for Ventas (VTR) Q1 Earnings, Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Ventas (VTR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Compound Your Wealth With These Undervalued Dividends
Planning for retirement requires a step-by-step approach and the power of compounding through dividend reinvestment and capital appreciation. Healthpeak Properties and Comcast are two undervalued picks with strong asset bases that offer potential for income and growth. Healthpeak Properties is...
What's in the Offing for Ventas (VTR) This Earnings Season?
Favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments are likely to have benefited Ventas' (VTR) Q1 earnings.
Source: https://incomestatements.info
Category: Stock Reports